Crohn's Disease Treatment Market

Crohn’s Disease Treatment Market by Type (Ileocolitis, Ileitis), Drug Type (Antibiotics, Amino Salicylates), Distribution Channel (Hospitals Pharmacy, Retail Pharmacy) – Global Outlook & Forecast 2023-2031

GR - 643056 Category: Pharmaceuticals

Number of pages: 100 | Report Format: PDF | Published date: April 05, 2023

Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031

Crohn's Disease Treatment Market Scope

Report Attribute	Details
Market Size Value in 2022	US$ 11.88 billion
Revenue Forecast in 2031	US$ 16.90 billion
CAGR	4%
Base Year for Estimation	2022
Forecast Period	2023-2031
Historical Year	2021
Segments covered	Type, Drug Type, Distribution Channel, and Region
Regional scope	North America, Europe, Asia Pacific, and the Rest of the World (RoW)

Report Overview

According to the deep-dive market assessment study by Growth Plus Reports, the global Crohn's disease treatment market was valued at US$ 11.88 billion in 2022 and is expected to register a revenue CAGR of 4% to reach US$ 16.90 billion by 2031.

Crohn's Disease Treatment Market Fundamentals

Crohn's disease is an inflammatory bowel disease (IBD) that causes chronic inflammation in the digestive tract. It can affect any part of the gastrointestinal tract, from the mouth to the anus, but most commonly affects the small intestine and the colon. Crohn's disease causes inflammation and ulcers in the lining of the digestive tract, leading to various symptoms. Some of Crohn's disease symptoms include abdominal pain, diarrhea, fatigue, weight loss, and malnutrition. The disease can also cause complications, such as strictures, fistulas, and abscesses. The exact cause of Crohn's disease is unknown, but it is believed to be related to genetic, environmental, and immune system factors. While there is no cure for Crohn's disease, treatment options are available to manage symptoms and reduce inflammation, and most people with the disease can live active and productive lives.

[43112]

Crohn's Disease Treatment Market Dynamics

Crohn's disease is increasing worldwide, which is a significant driver of the market. Much research and development is occurring in the Crohn's disease treatment market. New therapies are being developed, and existing drugs are being improved. Several promising drugs are in the pipeline for treating Crohn's disease, including biosimilars and novel drugs. These drugs have the potential to improve outcomes for patients. Moreover, the rise in the adoption of novel treatment options, such as biologics, has revolutionized the treatment of Crohn's disease. Biologics work by targeting specific molecules in the immune system that are responsible for inflammation. These drugs effectively treat Crohn's disease, and many new biologics are currently in development. With the advent of precision medicine, treatments for Crohn's disease are becoming more personalized. Physicians use genetic testing and other biomarkers to tailor treatment plans to individual patients. This approach has the potential to improve patient outcomes and reduce healthcare costs.

The global Crohn's disease treatment market revenue share is expected to continue growing during the forecast period, driven by advancements in research and the development of new therapies. The demand for the Crohn's disease treatment market is also expected to benefit from the increasing focus on personalized medicine, which involves tailoring treatments to individual patients based on their specific genetic and biological characteristics. However, there is still a significant unmet need for more effective and safe treatments, which presents an opportunity for drug developers to innovate and improve patient outcomes.

The market is competitive, with several major pharmaceutical companies, including AbbVie Inc., Janssen Biotech, Inc., Takeda Pharmaceutical Company Limited, and Pfizer Inc., holding significant Crohn's disease treatment market revenue share. There are also several smaller companies and startups developing new treatments for Crohn's disease, contributing to the Crohn's disease treatment market revenue growth.

As awareness of Crohn's disease and IBD grows, more people are being diagnosed with the condition. This is leading to increased demand for treatment options. Healthcare spending is increasing globally, benefiting Crohn's disease treatment market growth. Patients are willing to spend more on treatments to improve their quality of life and reduce symptoms. Many new drugs for Crohn's disease are being developed in oral formulations. This is a significant development as many existing treatments are administered by injection or infusion, which can be inconvenient for patients. Thus, this trend is also expected to boost Crohn's disease treatment market growth. However, the medications used to treat Crohn's disease can have significant side effects, including increased risk of infections, liver damage, and risk of certain types of cancer, which is restricting the Crohn's disease treatment market demand. The cost of treatment for Crohn's disease can be very high, particularly for biological therapies, which is also hindering the Crohn's disease treatment market growth.

Crohn's Disease Treatment Market Ecosystem

The global Crohn's disease treatment market is analyzed from four perspectives: type, drug type, distribution channel, and region.

Crohn's Disease Treatment Market by Type

[591995]

Based on the type, the global Crohn's disease treatment market is segmented into ileocolitis, ileitis, gastroduodenal Crohn's disease, jejunoileitis, and Crohn's colitis.

The ileocolitis segment accounted for the largest Crohn's disease treatment market share. Ileocolitis is the most common subtype of Crohn's disease. Ileocolitis can be a particularly severe form of Crohn's disease, with symptoms including abdominal pain, diarrhea, and rectal bleeding. As a result, patients with ileocolitis may require more aggressive treatment, including medications such as biologics and immunosuppressants. Due to the high prevalence and severity of ileocolitis, significant research has focused on developing new treatments for this disease. This has led to the development of several therapies specifically targeted at ileocolitis, which has further contributed to its dominance in the Crohn's disease treatment market revenue.

Crohn's Disease Treatment Market by Drug Type

Based on the drug type, the global Crohn's disease treatment market is segmented into antibiotics, aminosalicylates, corticosteroids, immunomodulators, and others.

The immunomodulators segment accounted for a significant market revenue share in 2022 because immunomodulators are often combined with other medications, including biologics. Biologics and immunomodulator medications can provide a synergistic effect that reduces inflammation and improves symptoms more effectively than either medication alone. Immunomodulators are often used as maintenance therapy for patients with Crohn's disease, meaning that they are taken regularly to prevent disease relapse. This is particularly important for patients who have achieved remission with other medications, as immunomodulators can help maintain that remission over the long term. Steroids are often used to reduce inflammation in the short term, but they can have significant side effects when used over the long term. Using immunomodulators in combination with other medications can reduce the need for steroids, improving treatment outcomes and reducing side effects. Moreover, immunomodulators are cost-effective, which is also propelling segmental revenue growth.

Crohn's Disease Treatment Market by Distribution Channel

Based on the distribution channel, the global Crohn's disease treatment market is segmented into hospitals, pharmacies, retail pharmacies, and online pharmacies.

The hospital's pharmacy segment dominated the market with the largest market revenue share in 2022. Hospitals are often the first point of care for patients with severe or complicated cases of Crohn's disease. Hospital pharmacies play a critical role in providing medications to patients who require hospitalization and managing the complex drug regimens that are often necessary to treat Crohn's disease. The medications used to treat Crohn's disease are specialty medications that require careful handling and storage. Hospital pharmacies are equipped to manage these medications and ensure that they are stored and administered to maintain their efficacy and safety. Hospital pharmacies play a critical role in coordinating care for patients with Crohn's disease. This includes working with physicians and other healthcare providers to ensure that patients receive the appropriate medications at the right time and that medication regimens are adjusted to optimize treatment outcomes.

The online pharmacy segment has the fastest revenue growth rate in terms of the Crohn's disease treatment market during the forecast period. Patients with Crohn's disease often require ongoing treatment and monitoring, which can be time-consuming and inconvenient. Online pharmacies offer the convenience of ordering medication from the comfort of their own homes, eliminating the need to travel to a physical pharmacy. Online pharmacies often offer lower prices than traditional brick-and-mortar pharmacies. This can be especially important for patients with chronic conditions like Crohn's disease, who may require ongoing medication.

Crohn's Disease Treatment Market by Region

Based on region, the global Crohn's disease treatment market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America accounts for the largest market revenue share in the global Crohn's disease market. The rising prevalence of inflammatory bowel disease (IBD) in the region is increasing the demand for effective treatment. According to the Centers for Disease Control and Prevention, an estimated 3.1 million adults, which accounts for 1.3% of the U.S., have been diagnosed with inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis. North America has a highly advanced healthcare infrastructure, well-developed healthcare systems, and a high level of government and non-government organizations investment. Many medications used to treat Crohn's disease are specialty medications that require careful handling and storage. North America has a well-developed system for distributing and managing specialty medications, ensuring patients can access the needed medications. North America has some of the highest healthcare spendings in the world, which allows for a high level of investment in medical research and development related to new treatments and therapies for Crohn's disease. The presence of the major players in the region and favorable reimbursement policies are also fueling regional revenue growth.

Competitive Landscape of Crohn's Disease Treatment Market

The prominent players operating in the global Crohn's disease treatment market are:

Abbvie Inc.
Janssen Biotech, Inc.
Takeda Pharmaceutical Company Limited
Pfizer Inc.
Bristol-Myers Squibb Company
Boehringer Ingelheim GmbH
AstraZeneca plc
Bayer AG
Novartis AG
Mylan N.V.
Amgen Inc.
Salix Pharmaceuticals Inc.

Strategic Developments in the Global Crohn's Disease Treatment Market

In February 2023, AbbVie received approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) for RINVOQ (upadacitinib), the first oral advanced therapy for adults with moderately to severely active Crohn's disease (CD). This approval marks the first marketing authorization globally for using upadacitinib in CD.
In October 2022, Verily and the Crohn's & Colitis Foundation announced an expanded strategic partnership. The collaboration will focus on building a longitudinal registry to accelerate research in Crohn's disease and ulcerative colitis, collectively known as inflammatory bowel disease (IBD). The registry will establish an infrastructure designed to rapidly answer clinical research questions in IBD, accelerate treatment development, and ultimately improve the quality of life for people with these diseases.
In August 2022, Samsung Bioepis Co., Ltd. and Organon & Co. received FDA approval for the citrate-free, high-concentration (100 mg/mL) formulation of HADLIMA (adalimumab-bwwd), a biosimilar referencing HUMIRA (adalimumab). HADLIMA will be available in a pre-filled syringe and autoinjector options, and the autoinjector was specifically designed with the patient in mind. HADLIMA was previously approved by the FDA as a low-concentration (50 mg/mL) formulation in July 2019. Outside the U.S., that formulation has been available in various markets globally under different brand names.

Frequently Asked Questions About This Report

The expected size of the global Crohn's disease treatment market in 2031 is US$ 16.90 billion.

Region-wise, North America has the largest market revenue share, followed by Europe, and Asia Pacific is expected to be the fastest-growing region during the forecast period.

The expected revenue CAGR of the global Crohn's disease treatment market is 4%.

The ileocolitis segment dominates the global Crohn's disease treatment market in terms of revenue share.

The side effects related to the medication and high costs are some restricting factors of the global market revenue.

Table of Content

INTRODUCTION
1. Market Ecosystem
2. Timeline Under Consideration
  1. Historical Years – 2021
  2. Base Year – 2022
  3. Forecast Years – 2023 to 2031
3. Currency Used in the Report
RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
  1. Secondary Sources
  2. Primary Sources
4. Market Estimation Approach
  1. Bottom Up
  2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
PREMIUM INSIGHTS
1. Current Market Trends (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2022)
3. Regulatory Landscape
4. Reimbursement Scenario
MARKET DYNAMICS
1. Drivers
2. Restraints/Challenges
3. Opportunities
GLOBAL CROHN’S DISEASE TREATMENT MARKET - ANALYSIS & FORECAST, BY TYPE
1. Ileocolitis
2. Ileitis
3. Gastroduodenal Crohn’s Disease
4. Jejunoileitis
5. Crohn’s Colitis
GLOBAL CROHN’S DISEASE TREATMENT MARKET - ANALYSIS & FORECAST, BY DRUG TYPE
1. Antibiotics
2. Amino Salicylates
3. Corticosteroids
4. Immunomodulators
5. Others
GLOBAL CROHN’S DISEASE TREATMENT MARKET - ANALYSIS & FORECAST, BY DISTRIBUTION CHANNEL
1. Hospitals Pharmacy
2. Retail Pharmacy
3. Online Pharmacy
GLOBAL CROHN’S DISEASE TREATMENT MARKET - ANALYSIS & FORECAST, BY REGION
1. North America Crohn’s Disease Treatment Market
  1. North America Crohn’s Disease Treatment Market, by Type
  2. North America Crohn’s Disease Treatment Market, by Drug Type
  3. North America Crohn’s Disease Treatment Market, by Distribution Channel
  4. North America Crohn’s Disease Treatment Market, by Country
    1. U.S.
      1. U.S. Crohn’s Disease Treatment Market, by Type
      2. U.S. Crohn’s Disease Treatment Market, by Drug Type
      3. U.S. Crohn’s Disease Treatment Market, by Distribution Channel
    2. Canada
      1. Canada Crohn’s Disease Treatment Market, by Type
      2. Canada Crohn’s Disease Treatment Market, by Drug Type
      3. Canada Crohn’s Disease Treatment Market, by Distribution Channel
2. Europe Crohn’s Disease Treatment Market
  1. Europe Crohn’s Disease Treatment Market, by Type
  2. Europe Crohn’s Disease Treatment Market, by Drug Type
  3. Europe Crohn’s Disease Treatment Market, by Distribution Channel
  4. Europe Crohn’s Disease Treatment Market, by Country/Region
    1. Germany
      1. Germany Crohn’s Disease Treatment Market, by Type
      2. Germany Crohn’s Disease Treatment Market, by Drug Type
      3. Germany Crohn’s Disease Treatment Market, by Distribution Channel
    2. U.K.
      1. U.K. Crohn’s Disease Treatment Market, by Type
      2. U.K. Crohn’s Disease Treatment Market, by Drug Type
      3. U.K. Crohn’s Disease Treatment Market, by Distribution Channel
    3. France
      1. France Crohn’s Disease Treatment Market, by Type
      2. France Crohn’s Disease Treatment Market, by Drug Type
      3. France Crohn’s Disease Treatment Market, by Distribution Channel
    4. Spain
      1. Spain Crohn’s Disease Treatment Market, by Type
      2. Spain Crohn’s Disease Treatment Market, by Drug Type
      3. Spain Crohn’s Disease Treatment Market, by Distribution Channel
    5. Italy
      1. Italy Crohn’s Disease Treatment Market, by Type
      2. Italy Crohn’s Disease Treatment Market, by Drug Type
      3. Italy Crohn’s Disease Treatment Market, by Distribution Channel
    6. Rest of Europe
      1. Rest of Europe Crohn’s Disease Treatment Market, by Type
      2. Rest of Europe Crohn’s Disease Treatment Market, by Drug Type
      3. Rest of Europe Crohn’s Disease Treatment Market, by Distribution Channel
3. Asia Pacific Crohn’s Disease Treatment Market
  1. Asia Pacific Crohn’s Disease Treatment Market, by Type
  2. Asia Pacific Crohn’s Disease Treatment Market, by Drug Type
  3. Asia Pacific Crohn’s Disease Treatment Market, by Distribution Channel
  4. Asia Pacific Crohn’s Disease Treatment Market, by Country/Region
    1. China
      1. China Crohn’s Disease Treatment Market, by Type
      2. China Crohn’s Disease Treatment Market, by Drug Type
      3. China Crohn’s Disease Treatment Market, by Distribution Channel
    2. Japan
      1. Japan Crohn’s Disease Treatment Market, by Type
      2. Japan Crohn’s Disease Treatment Market, by Drug Type
      3. Japan Crohn’s Disease Treatment Market, by Distribution Channel
    3. India
      1. India Crohn’s Disease Treatment Market, by Type
      2. India Crohn’s Disease Treatment Market, by Drug Type
      3. India Crohn’s Disease Treatment Market, by Distribution Channel
    4. South Korea
      1. South Korea Crohn’s Disease Treatment Market, by Type
      2. South Korea Crohn’s Disease Treatment Market, by Drug Type
      3. South Korea Crohn’s Disease Treatment Market, by Distribution Channel
    5. Australia
      1. Australia Crohn’s Disease Treatment Market, by Type
      2. Australia Crohn’s Disease Treatment Market, by Drug Type
      3. Australia Crohn’s Disease Treatment Market, by Distribution Channel
    6. Rest of Asia Pacific
      1. Rest of Asia Pacific Crohn’s Disease Treatment Market, by Type
      2. Rest of Asia Pacific Crohn’s Disease Treatment Market, by Drug Type
      3. Rest of Asia Pacific Crohn’s Disease Treatment Market, by Distribution Channel
4. Latin America Crohn’s Disease Treatment Market
  1. Latin America Crohn’s Disease Treatment Market, by Type
  2. Latin America Crohn’s Disease Treatment Market, by Drug Type
  3. Latin America Crohn’s Disease Treatment Market, by Distribution Channel
  4. Latin America Crohn’s Disease Treatment Market, by Country/Region
    1. Brazil
      1. Brazil Crohn’s Disease Treatment Market, by Type
      2. Brazil Crohn’s Disease Treatment Market, by Drug Type
      3. Brazil Crohn’s Disease Treatment Market, by Distribution Channel
    2. Mexico
      1. Mexico Crohn’s Disease Treatment Market, by Type
      2. Mexico Crohn’s Disease Treatment Market, by Drug Type
      3. Mexico Crohn’s Disease Treatment Market, by Distribution Channel
    3. Argentina
      1. Argentina Crohn’s Disease Treatment Market, by Type
      2. Argentina Crohn’s Disease Treatment Market, by Drug Type
      3. Argentina Crohn’s Disease Treatment Market, by Distribution Channel
    4. Rest of Latin America
      1. Rest of Latin America Crohn’s Disease Treatment Market, by Type
      2. Rest of Latin America Crohn’s Disease Treatment Market, by Drug Type
      3. Rest of Latin America Crohn’s Disease Treatment Market, by Distribution Channel
5. Middle East & Africa Crohn’s Disease Treatment Market
  1. Middle East & Africa Crohn’s Disease Treatment Market, by Type
  2. Middle East & Africa Crohn’s Disease Treatment Market, by Drug Type
  3. Middle East & Africa Crohn’s Disease Treatment Market, by Distribution Channel
  4. Middle East & Africa Crohn’s Disease Treatment Market, by Country/Region
    1. GCC Countries
      1. GCC Countries Crohn’s Disease Treatment Market, by Type
      2. GCC Countries Crohn’s Disease Treatment Market, by Drug Type
      3. GCC Countries Crohn’s Disease Treatment Market, by Distribution Channel
    2. South Africa
      1. South Africa Crohn’s Disease Treatment Market, by Type
      2. South Africa Crohn’s Disease Treatment Market, by Drug Type
      3. South Africa Crohn’s Disease Treatment Market, by Distribution Channel
    3. Rest of Middle East & Africa
      1. Rest of Middle East & Africa Crohn’s Disease Treatment Market, by Type
      2. Rest of Middle East & Africa Crohn’s Disease Treatment Market, by Drug Type
      3. Rest of Middle East & Africa Crohn’s Disease Treatment Market, by Distribution Channel
COMPANY PROFILES
1. Abbvie Inc.
  1. Business Snapshot
  2. Products Offered
  3. Financial Details
  4. Strategic Development
2. Janssen Biotech, Inc.
3. Takeda Pharmaceutical Company Limited
4. Pfizer Inc.
5. Bristol-Myers Squibb Company
6. Boehringer Ingelheim GmbH
7. AstraZeneca plc
8. Bayer AG
9. Novartis AG
10. Mylan N.V.
11. Amgen Inc.
12. Salix Pharmaceuticals Inc.

*Insights on financial performance are subject to the availability of information in the public domain

List of Tables

Global Crohn’s Disease Treatment Market, by Type, 2021-2031 (US$ Million)
Global Crohn’s Disease Treatment Market, by Drug Type, 2021–2031 (US$ Million)
Global Crohn’s Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million)
Global Crohn’s Disease Treatment Market, by Region, 2021-2031 (US$ Million)
North America Crohn’s Disease Treatment Market, by Type, 2021-2031 (US$ Million)
North America Crohn’s Disease Treatment Market, by Drug Type, 2021–2031 (US$ Million)
North America Crohn’s Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million)
North America Crohn’s Disease Treatment Market, by Country, 2021-2031 (US$ Million)
U.S. Crohn’s Disease Treatment Market, by Type, 2021-2031 (US$ Million)
U.S. Crohn’s Disease Treatment Market, by Drug Type, 2021–2031 (US$ Million)
U.S. Crohn’s Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million)
Canada Crohn’s Disease Treatment Market, by Type, 2021-2031 (US$ Million)
Canada Crohn’s Disease Treatment Market, by Drug Type, 2021–2031 (US$ Million)
Canada Crohn’s Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million)
Europe Crohn’s Disease Treatment Market, by Type, 2021-2031 (US$ Million)
Europe Crohn’s Disease Treatment Market, by Drug Type, 2021–2031 (US$ Million)
Europe Crohn’s Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million)
Europe Crohn’s Disease Treatment Market, by Country/Region, 2021-2031 (US$ Million)
Germany Crohn’s Disease Treatment Market, by Type, 2021-2031 (US$ Million)
Germany Crohn’s Disease Treatment Market, by Drug Type, 2021–2031 (US$ Million)
Germany Crohn’s Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million)
U.K. Crohn’s Disease Treatment Market, by Type, 2021-2031 (US$ Million)
U.K. Crohn’s Disease Treatment Market, by Drug Type, 2021–2031 (US$ Million)
U.K. Crohn’s Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million)
France Crohn’s Disease Treatment Market, by Type, 2021-2031 (US$ Million)
France Crohn’s Disease Treatment Market, by Drug Type, 2021–2031 (US$ Million)
France Crohn’s Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million)
Italy Crohn’s Disease Treatment Market, by Type, 2021-2031 (US$ Million)
Italy Crohn’s Disease Treatment Market, by Drug Type, 2021–2031 (US$ Million)
Italy Crohn’s Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million)
Spain Crohn’s Disease Treatment Market, by Type, 2021-2031 (US$ Million)
Spain Crohn’s Disease Treatment Market, by Drug Type, 2021–2031 (US$ Million)
Spain Crohn’s Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million)
Rest of Europe Crohn’s Disease Treatment Market, by Type, 2021-2031 (US$ Million)
Rest of Europe Crohn’s Disease Treatment Market, by Drug Type, 2021–2031 (US$ Million)
Rest of Europe Crohn’s Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million)
Asia Pacific Crohn’s Disease Treatment Market, by Type, 2021-2031 (US$ Million)
Asia Pacific Crohn’s Disease Treatment Market, by Drug Type, 2021–2031 (US$ Million)
Asia Pacific Crohn’s Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million)
Asia Pacific Crohn’s Disease Treatment Market, by Country/Region, 2021-2031 (US$ Million)
China Crohn’s Disease Treatment Market, by Type, 2021-2031 (US$ Million)
China Crohn’s Disease Treatment Market, by Drug Type, 2021–2031 (US$ Million)
China Crohn’s Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million)
Japan Crohn’s Disease Treatment Market, by Type, 2021-2031 (US$ Million)
Japan Crohn’s Disease Treatment Market, by Drug Type, 2021–2031 (US$ Million)
Japan Crohn’s Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million)
India Crohn’s Disease Treatment Market, by Type, 2021-2031 (US$ Million)
India Crohn’s Disease Treatment Market, by Drug Type, 2021–2031 (US$ Million)
India Crohn’s Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million)
South Korea Crohn’s Disease Treatment Market, by Type, 2021-2031 (US$ Million)
South Korea Crohn’s Disease Treatment Market, by Drug Type, 2021–2031 (US$ Million)
South Korea Crohn’s Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million)
Australia Crohn’s Disease Treatment Market, by Type, 2021-2031 (US$ Million)
Australia Crohn’s Disease Treatment Market, by Drug Type, 2021–2031 (US$ Million)
Australia Crohn’s Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million)
Rest of Asia Pacific Crohn’s Disease Treatment Market, by Type, 2021-2031 (US$ Million)
Rest of Asia Pacific Crohn’s Disease Treatment Market, by Drug Type, 2021–2031 (US$ Million)
Rest of Asia Pacific Crohn’s Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million)
Latin America Crohn’s Disease Treatment Market, by Type, 2021-2031 (US$ Million)
Latin America Crohn’s Disease Treatment Market, by Drug Type, 2021–2031 (US$ Million)
Latin America Crohn’s Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million)
Latin America Crohn’s Disease Treatment Market, by Country/Region, 2021–2031 (US$ Million)
Brazil Crohn’s Disease Treatment Market, by Type, 2021-2031 (US$ Million)
Brazil Crohn’s Disease Treatment Market, by Drug Type, 2021–2031 (US$ Million)
Brazil Crohn’s Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million)
Mexico Crohn’s Disease Treatment Market, by Type, 2021-2031 (US$ Million)
Mexico Crohn’s Disease Treatment Market, by Drug Type, 2021–2031 (US$ Million)
Mexico Crohn’s Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million)
Argentina Crohn’s Disease Treatment Market, by Type, 2021-2031 (US$ Million)
Argentina Crohn’s Disease Treatment Market, by Drug Type, 2021–2031 (US$ Million)
Argentina Crohn’s Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million)
Rest of Latin America Crohn’s Disease Treatment Market, by Type, 2021-2031 (US$ Million)
Rest of Latin America Crohn’s Disease Treatment Market, by Drug Type, 2021–2031 (US$ Million)
Rest of Latin America Crohn’s Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million)
Middle East and Africa Crohn’s Disease Treatment Market, by Type, 2021-2031 (US$ Million)
Middle East and Africa Crohn’s Disease Treatment Market, by Drug Type, 2021–2031 (US$ Million)
Middle East and Africa Crohn’s Disease Treatment Market, by Distribution Channel 2021–2031 (US$ Million)
Middle East and Africa Crohn’s Disease Treatment Market, by Country/Region, 2021–2031 (US$ Million)
GCC Countries Crohn’s Disease Treatment Market, by Type, 2021-2031 (US$ Million)
GCC Countries Crohn’s Disease Treatment Market, by Drug Type, 2021–2031 (US$ Million)
GCC Countries Crohn’s Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million)
South Africa Crohn’s Disease Treatment Market, by Type, 2021-2031 (US$ Million)
South Africa Crohn’s Disease Treatment Market, by Drug Type, 2021–2031 (US$ Million)
South Africa Crohn’s Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million)
Rest of Middle East & Africa Crohn’s Disease Treatment Market, by Type, 2021-2031 (US$ Million)
Rest of Middle East & Africa Crohn’s Disease Treatment Market, by Drug Type, 2021–2031 (US$ Million)
Rest of Middle East & Africa Crohn’s Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million)

List of Figures

Crohn’s Disease Treatment Market Ecosystem
Snapshot of Global Crohn’s Disease Treatment Market, 2021-2031
Snapshot of Global Crohn’s Disease Treatment Market, by Region, 2021-2031
Global Crohn’s Disease Treatment Market: COVID-19 Pandemic Impact Assessment
Global Crohn’s Disease Treatment Market: Key Players & Competitive Positioning (2022)
Crohn’s Disease Treatment: Market Dynamics
Global Crohn’s Disease Treatment Market for Ileocolitis, 2021-2031 (US$ Million)
Global Crohn’s Disease Treatment Market for Ileitis, 2021-2031 (US$ Million)
Global Crohn’s Disease Treatment Market for Gastroduodenal Crohn’s Disease, 2021-2031 (US$ Million)
Global Crohn’s Disease Treatment Market for Jejunoileitis, 2021-2031 (US$ Million)
Global Crohn’s Disease Treatment Market for Crohn’s Colitis, 2021-2031 (US$ Million)
Global Antibiotics for Crohn’s Disease Treatment Market, 2021-2031 (US$ Million)
Global Amino Salicylates for Crohn’s Disease Treatment Market, 2021-2031 (US$ Million)
Global Corticosteroids for Crohn’s Disease Treatment Market, 2021-2031 (US$ Million)
Global Immunomodulators for Crohn’s Disease Treatment Market, 2021-2031 (US$ Million)
Global Others for Crohn’s Disease Treatment Market, 2021-2031 (US$ Million)
Global Crohn’s Disease Treatment Market for Hospitals Pharmacy, 2021-2031 (US$ Million)
Global Crohn’s Disease Treatment Market for Retail Pharmacy, 2021-2031 (US$ Million)
Global Crohn’s Disease Treatment Market for Online Pharmacy, 2021-2031 (US$ Million)
North America Crohn’s Disease Treatment Market, 2021-2031 (US$ Million)
U.S. Crohn’s Disease Treatment Market, 2021-2031 (US$ Million)
Canada Crohn’s Disease Treatment Market, 2021-2031 (US$ Million)
Europe Crohn’s Disease Treatment Market, 2021-2031 (US$ Million)
Germany Crohn’s Disease Treatment Market, 2021-2031 (US$ Million)
U.K. Crohn’s Disease Treatment Market, 2021-2031 (US$ Million)
France Crohn’s Disease Treatment Market, 2021-2031 (US$ Million)
Italy Crohn’s Disease Treatment Market, 2021-2031 (US$ Million)
Spain Crohn’s Disease Treatment Market, 2021-2031 (US$ Million)
Rest of Europe Crohn’s Disease Treatment Market, 2021-2031 (US$ Million)
Asia Pacific Crohn’s Disease Treatment Market, 2021-2031 (US$ Million)
China Crohn’s Disease Treatment Market, 2021-2031 (US$ Million)
Japan Crohn’s Disease Treatment Market, 2021-2031 (US$ Million)
India Crohn’s Disease Treatment Market, 2021-2031 (US$ Million)
South Korea Crohn’s Disease Treatment Market, 2021-2031 (US$ Million)
Australia Crohn’s Disease Treatment Market, 2021-2031 (US$ Million)
Rest of Asia Pacific Crohn’s Disease Treatment Market, 2021-2031 (US$ Million)
Latin America Crohn’s Disease Treatment Market, 2021-2031 (US$ Million)
Brazil Crohn’s Disease Treatment Market, 2021-2031 (US$ Million)
Mexico Crohn’s Disease Treatment Market, 2021-2031 (US$ Million)
Argentina Crohn’s Disease Treatment Market, 2021-2031 (US$ Million)
Rest of Latin America Crohn’s Disease Treatment Market, 2021-2031 (US$ Million)
Middle East & Africa Crohn’s Disease Treatment Market, 2021-2031 (US$ Million)
GCC Countries Crohn’s Disease Treatment Market, 2021-2031 (US$ Million)
South Africa Crohn’s Disease Treatment Market, 2021-2031 (US$ Million)
Rest of Middle East & Africa Crohn’s Disease Treatment Market, 2021-2031 (US$ Million)
Abbvie Inc. Revenue from 2019 Onwards (US$ Million)
Janssen Biotech, Inc. Revenue from 2019 Onwards (US$ Million)
Takeda Pharmaceutical Company Limited Revenue from 2019 Onwards (US$ Million)
Pfizer Inc. Revenue from 2019 Onwards (US$ Million)
Bristol-Myers Squibb Company Revenue from 2019 Onwards (US$ Million)
Boehringer Ingelheim GmbH Revenue from 2019 Onwards (US$ Million)
AstraZeneca plc Revenue from 2019 Onwards (US$ Million)
Bayer AG Revenue from 2019 Onwards (US$ Million)
Novartis AG Revenue from 2019 Onwards (US$ Million)
Mylan N.V. Revenue from 2019 Onwards (US$ Million)
Amgen Inc. Revenue from 2019 Onwards (US$ Million)
Salix Pharmaceuticals Inc. Revenue from 2019 Onwards (US$ Million)

Single User License

Multi User License

Enterprise User License

$4,750.00

What are the significant driving and restraining factors for the Crohn's Disease Treatment Market?
Who are the leading companies in the market?
Where can you find the updates on recent developments by market players?
When is the right time to get discounts on complete market reports?
Why to invest in the Crohn's Disease Treatment Market?
How to improve your organizational performance?
How to shift customers towards your brand?

Ask For Customization Check Discount Inquire Before Buying

Recommended Reports